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The goal of the present study was to examine possible effects of right
median nerve stimulation (RMNS) on memory in patients in a relatively
early stage of probable Alzheimer’s disease (AD). Seventeen AD patients
were randomly assigned to an experimental group (n ¼ 8) and a control group
(n ¼ 9) and treated with RMNS and sham RMNS, respectively, for 30min a day,
5 days aweek, for 6weeks.Neuropsychological tests were used to assessmemory pro-
cesses. The results show that the various aspects ofmemory did not respond positively
to RMNS. A study with a much longer treatment period is suggested before firm
conclusions about the ineffectiveness of RMNS on memory in AD can be drawn.
In previous studies, the effects of transcutaneous electrical nerve
stimulation (TENS) on various aspects of memory were examined
in patients with probable Alzheimer’s disease (AD). In those studies,
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various aspects of memory, particularly episodic and semantic mem-
ory, showed a statistically significant improvement, despite the rela-
tively small number of patients that participated in each study
(Scherder, Bouma, & Steen, 1995, 1998; Scherder & Bouma, 1999).
Of note is that a recent larger study failed to find positive effects of
TENS on memory in AD patients (Van Dijk, Scheltens, Luijpen, Ser-
geant, & Scherder, 2005). One rationale that underlies these studies is
that TENS enhances the activity of the ascending reticular activating
system (ARAS) through stimulation of the locus coeruleus and dorsal
raphe nucleus, brain stem areas that are the origin of the noradrener-
gic and serotonergic neurotransmitter systems, respectively (Kayama
& Koyama, 1999). To activate the ARAS, the electrical current in the
TENS studies was applied through two electrodes placed on the mus-
culus trapezius pars descendens, between the first and fifth thoracic
vertebrae, with an intensity high enough to provoke mild non-
nociceptive muscular contractions of the musculus trapezius.
However, the application of the electrodes on the musculus trape-
zius is quite impractical on a psychogeriatric ward with a large num-
ber of patients and a small nursing staff. The electrodes are hidden
underneath the clothing and, consequently, the muscular contraction
of the musculus trapezius pars descendens can only be controlled for
by a close inspection. A more practical alternative might be to stimu-
late the patient through electrodes over the median nerve of, e.g., the
right forearm, called right median nerve stimulation (RMNS). This
electrode placement requires hardly any undressing and enables the
nursing staff to control for muscular contractions at a distance
because there is no need to cover the electrodes by clothing. In clinical
studies, RMNS has only been applied to coma patients and appeared
to accelerate awakening from deep coma (Cooper, Jane, Alves, &
Cooper, 1999; Peri et al., 2001; Cooper & Cooper, 2003; Liu et al.,
2003). Similar to the TENS studies in AD, the rationale underlying
the coma studies is that RMNS stimulates the ARAS (Cooper et al.,
1999; Cooper, Scherder, & Cooper, 2005). Based on the positive effects
of RMNS in coma, we investigated in the present study whether
RMNS could improve memory in patients with probable AD.
METHODS
Subjects
Seventeen subjects met the NINCDS-ADRDA criteria for the clinical
diagnosis of probable AD (McKhann et al., 1984) and stage 5 of the
Global Deterioration Scale (GDS) (Reisberg, Ferris, De Leon, &
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Crook, 1982), in the absence of a history of psychiatric disorder,
alcoholism, cerebral trauma, cerebrovascular disease, hydrocephalus,
neoplasm, epilepsy, disturbances of consciousness, or focal brain
disorders. None of the subjects had a pacemaker. Patients were
randomly assigned to an experimental group (n ¼ 8) and a control
group (n ¼ 9). The level of cognitive functioning was measured by
the Mini-Mental State Examination (MMSE), with a maximum score
of 30 (Folstein, Folstein, & McHugh, 1975).
After description of the study to the patients and their families,
written informed consent was obtained from both. The local Medical
Ethical Committee approved the study.
Procedures
Treatment
RMNS was applied to the patients in the experimental group by an
electrostimulator, type Premier 10 s. This stimulator generated asym-
metric biphasic square electrical impulses in bursts of trains (Scherder
et al., 1995) via two surface rubber electrodes placed on the volar side
of the patient’s right distal forearm over the median nerve (Cooper
et al., 1999). The AD patients in the control group received sham
stimulation, i.e., no current was administered. All 17 patients received
a 30-min=day treatment between 15:00 and 19:00 h, for 5 days=week,
during a 6-week period.
Assessment of Memory
To evaluate possible treatment effects of RMNS on memory, the
following neuropsychological tests were administered. Digit Span For-
ward and Backward (ForwardþBackward ¼ Total score) and Visual
Memory Span Forward and Backward (ForwardþBackward ¼ Total
Total Score) (Wechsler, 1987) were used to assess patients’ verbal and
nonverbal short-term memory capacities, respectively. The California
Verbal Learning Test (Delis, Kramer, Kaplan, & Ober, 1987) includes
a list of 16 words (groceries and clothing) and was used to assess vari-
ous types of recall from episodic memory, i.e., recall immediately after
the presentation of the words: Immediate Recall (total score after pre-
senting the words five times), Delayed Recall (recall after 15min), and
Recognition (recall by means of recognition). Face and Picture Recog-
nition (Wilson, Cockburn, & Baddeley, 1987) provided a measure of
visual and verbal long-term recognition memory, respectively, and
Word Fluency (Snijders & Verhage, 1983) was meant to measure sem-
antic memory. An independent investigator who was not informed
about which subjects belonged to which group administered the tests.
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Data Analyses
Neuropsychological testing took place immediately before the 6weeks of
stimulation (pretreatment), directly after this period (post treatment),
and following another period of 6 weeks without stimulation (delayed).
The pretreatment scores were submitted to t tests to verify that no differ-
ence existed between the two groups at the start of the experiment.
To calculate a possible treatment effect of RMNS on cognitive
functioning, the pretreatment scores were subtracted from the post-
treatment scores of both the experimental and the control group (differ-
ence scores). To evaluate whether possible treatment effects remained or
disappeared after cessation of stimulation, the scores obtained after the
treatment-free period (delayed scores) were subtracted from the post-
treatment scores (difference scores) in both groups. Independent-sample
t tests for the main effect of treatment were performed on these differ-
ence scores. A confidence coefficient of 95% was used for confidence
interval (CI). A Bonferroni correction was applied to the significance
level of p < .05, resulting in a critical value of p < .006. When a signifi-
cant difference between both groups after treatment failed, but the mean
post-treatment scores were in the expected direction, i.e., a higher mean
score in the experimental group and a hardly unchanged or a lower
mean score in the control group, the number of patients necessary to
reach the level of significance was calculated by means of a power analy-
sis (PASS; NCSS Statistical Software, Kaysville, UT). The SPSS-PC
program (Norusis, 1992) was used to analyze the data.
RESULTS
Demographic Characteristics
The experimental group and the control group did not differ signifi-
cantly in age (t(15) ¼ 0.17; p ¼ .87), education (t(15) ¼ 0.44; p ¼ .67),
and level of cognitive functioning measured by the MMSE
(t(15) ¼ 0.31; p ¼ .76). Details on demographic variables and MMSE
scores are presented in Table 1.
Treatment Effects
The test scores showed a normal pattern of distribution, and no out-
liers were found in the sample. The results of the t tests on the pre-
treatment scores showed no significant differences between the
experimental and control group (for means, standard deviations,
and t tests, see Table 2).
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Analyses of treatment efficacy by applying independent t tests to
the difference scores of post-treatment minus pretreatment scores
and post-treatment minus delayed treatment scores of both the
experimental and control group are presented in Tables 3 and 4.
Compared to sham stimulation, RMNS did not significantly improve
the performance on the various memory tests.
Of note is that the mean (difference) scores in Tables 3 and 4,
respectively, show that the performance on only two tests, i.e., the
CVLT Immediate Recall and Word Fluency were in the expected
direction (see Data Analyses). For the two tests to reach a level of sig-
nificance, a power analyses with b ¼ .80 and a ¼ .006 revealed that
21 and 155 patients, respectively, should be included in each group
(Table 3). With respect to the other tests, patients of the experimental
group showed a lower performance on Digit Span Total score, CVLT
Delayed and Recognition, and Face Recognition after treatment. On
two tests, i.e., Visual Memory Span Total score and CVLT Recog-
nition, the mean scores of the control group were even higher com-
pared to the mean scores of the experimental group.
DISCUSSION
The results of the present study show that right median nerve stimu-
lation (RMNS) did not improve the various aspects of memory in
AD patients. Compared to the mean pretreatment scores, only the
mean post-treatment scores on the CVLT Immediate Recall and
Word Fluency were higher in the experimental group and remained
level in the control group (Tables 3 and 4). A power analysis showed
that for the two tests to become statistically significant, each group
should include 21 and 155 patients, respectively. Although in the
Table 1. Demographic characteristics of the subject sample
Experimental group (n ¼ 8) Control group (n ¼ 9)
2=6 2=7
Male=female ratio Mean SD Mean SD
Age (range) 85.00 (76–92) 6.21 85.44 (77–90) 4.77
Education 3.25 .71 3.11 0.60
MMSE (range) 19.50 (12–24) 4.18 18.89 (12–25) 4.95
Note. MMSE: Mini-Mental State Examination.
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present study the inclusion of a homogeneous group of seventeen AD
patients took about 2 years, a number of 21 patients in each group
(42 in total) would still be feasible. However, a statistically significant
effect on CVLT Immediate Recall—an episodic memory test—does
not automatically mean a clinical relevant effect. In previous studies,
in which statistically significant effects were observed for tests appeal-
ing to episodic memory, patients did not show a ‘clinical’ improve-
ment (Scherder et al., 1995, 1998; Scherder & Bouma, 1999). A
possible clinical effect of RMNS on episodic memory in case of a lar-
ger sample size is further weakened by the finding that after 6 weeks
of treatment the experimental group showed lower scores on other
episodic memory tests: the subtests Delayed Recall and Recognition
of the CVLT and Face Recognition. The improved performance on
the episodic memory test Picture Recognition has been observed in
both the experimental and control group and can therefore not be
ascribed to RMNS.
Table 3. t tests on the post-treatment (Post) minus pretreatment (Pre) scores
(difference scores) of the neuropsychological tests of the experimental (Exp)
and control (Co) groups
Neuropsychological
tests
Post minus Pre: difference scores t tests
Group M SE 95%CI t df p N
Digit Span Total score Exp .13 .64 1.64–1.38 .79 15 .44
Co .78 .91 1.32–2.87
Vis. Mem. Span
Total score
Exp .88 .30 1.59– .17 1.20 15 .25
Co 2.11 .94 .06–4.28
CVLT Immediate Recall Exp 3.37 1.46 .07–6.83 2.16 15 .054 21
Co .45 1.04 3.28–2.40 21
CVLT Delayed Recall Exp .25 .16 .63–2.12 1.63 15 .13
Co .00 .00
CVLT Recognition Exp .25 2.71 6.66–6.16 .55 15 .59
Co 2.00 3.04 5.01–9.01
Face Recognition Exp 2.25 2.84 8.97–4.47 .05 15 .96
Co 2.44 2.82 8.94–4.06
Picture Recognition Exp 2.25 2.79 4.35–8.85 .23 15 .92
Co 1.33 2.73 4.97–7.63
Word Fluency Exp 1.13 1.34 2.04–4.30 .78 15 .45 155
Co .29 1.22 3.10–2.52 155
Note. CVLT: California Verbal Learning Test.
N ¼ Number of patients necessary to reach the level of significance: p < .006; only calculated
for those tests of which the post-treatment scores were in the expected direction, i.e., a higher
mean score in the experimental group and an unchanged or lower score in the control group.
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In order to obtain a statistically significant effect of RMNS on
Word Fluency, a homogeneous group of 310 AD patients should par-
ticipate. To include such a large number of patients is not realistic.
Moreover, similar to an improvement in episodic memory tests, a
statistically significant higher score on Word Fluency alone does
not imply an observable clinical improvement of patient’s cognitive
functioning (Scherder et al., 1998).
Because this is the first study on RMNS in AD, effect sizes, and
consequently, the number of patients that should participate, could
not be estimated before the start of the study. In our opinion, a pilot
study on a new type of intervention that is very time-consuming and
therefore costly requires an evaluation of the direction of the scores in
each group, after an initial phase with a feasible number of patients.
The present data show that in this group of AD patients clinically rel-
evant effects will not be obtained with this RMNS procedure. There-
fore, we feel it is justified to discontinue the present study of RMNS
as a treatment of memory in AD patients and make suggestions
about modifications of stimulation-parameters that might result in
more profound cognitive improvements.
Table 4. t tests on the post-treatment scores (Post) minus delayed scores
(Delayed) (difference scores) of the neuropsychological tests of the experi-
mental (Exp) and control (Co) groups
Post minus Delayed: difference scores t tests
Neuropsychological tests Group M SE 95%CI t df p
Digit Span Total score Exp  .13 .55  1.43–1.17 .32 15 .75
Co  .46 .85  2.42–1.50
Visual Memory Span
Total score
Exp .75 .45  .31–1.81 .86 15 .41
Co 1.44 .65  .06–2.94
CVLT Immediate Recall Exp .88 1.39  2.41–4.17 1.45 15 .17
Co  1.94 1.34  5.03–1.15
CVLT Delayed Recall Exp  .13 .23  .67– .41 .03 15 .59
Co  .13 .11  .38– .12
CVLT Recognition Exp 7.25 4.73  3.94–18.44 1.06 15 .30
Co 2.07 1.87  2.35–6.49
Face Recognition Exp  .50 1.30  3.57–3.57 .51 15 .62
Co  2.13 2.78  8.70–4.44
Picture Recognition Exp  2.95 2.30  8.39–2.49 .09 15 .93
Co  3.29 2.84  9.84–3.26
Word Fluency Exp  .38 1.10  2.98–2.22 1.06 15 .31
Co  2.73 1.84  6.97–1.51
Note. CVLT: California Verbal Learning Test.
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One suggestion for a more effective RMNS treatment concerns the
duration of the treatment period. For the sake of comparability, the
study design of the present study and of the TENS studies (Scherder
et al., 1995, 1998; Scherder & Bouma, 1999) was exactly the same:
stimulation took place for 30min each day, 5 days a week, during
a period of 6 weeks. However, studies examining other types of non-
pharmacological interventions such as daily physical activity
observed some cognitive improvement in patients with dementia after
6 weeks but more pronounced after 12 weeks of treatment (Van de
Winckel, Feys, de Weerdt, & Dom, 2004). In a recent review on the
effects of fitness on cognitive functioning of elderly people, long-term
training programs (>6 months) were more effective than programs
of shorter duration (Colcombe & Kramer, 2003). Considering the
possible clinical importance of RMNS in dementia, e.g., easy to apply
and little side effects, it is suggested that a study with a much longer
treatment period is required before definite conclusions about the
ineffectiveness of RMNS in AD can be drawn.
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